➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Colorcon
AstraZeneca
Merck
Johnson and Johnson

Last Updated: September 25, 2021

DrugPatentWatch Database Preview

TESTOSTERONE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Testosterone patents expire, and when can generic versions of Testosterone launch?

Testosterone is a drug marketed by Actavis Labs Ut Inc, Aleor Dermaceuticals, Amneal, Dr Reddys, Lupin, Perrigo Israel, Twi Pharms, Xiromed, Ani Pharms, Padagis Israel, Par Pharm, Watson Labs, Apotex, Cipla, Dash Pharms, Lupin Ltd, Am Regent, Hikma, Hikma Farmaceutica, Mylan Institutional, Padagis Us, Sandoz Inc, Sun Pharm Inds Ltd, Watson Pharms Inc, Wilshire Pharms Inc, Nexus Pharms, Bel Mar, Elkins Sinn, and Lilly. and is included in fifty-four NDAs.

The generic ingredient in TESTOSTERONE is testosterone propionate. There are sixty-nine drug master file entries for this compound. Additional details are available on the testosterone propionate profile page.

Drug patent expirations by year for TESTOSTERONE
Drug Prices for TESTOSTERONE

See drug prices for TESTOSTERONE

Drug Sales Revenue Trends for TESTOSTERONE

See drug sales revenues for TESTOSTERONE

Recent Clinical Trials for TESTOSTERONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of UtahPhase 2
Region Jönköping CountyPhase 3
Stockholm South General HospitalPhase 3

See all TESTOSTERONE clinical trials

Pharmacology for TESTOSTERONE
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for TESTOSTERONE
Paragraph IV (Patent) Challenges for TESTOSTERONE
Tradename Dosage Ingredient NDA Submissiondate
AXIRON SOLUTION, METERED;TRANSDERMAL testosterone 022504 2013-01-29
FORTESTA GEL, METERED;TRANSDERMAL testosterone 021463 2012-08-14
TESTIM GEL;TRANSDERMAL testosterone 021454 2008-08-21

US Patents and Regulatory Information for TESTOSTERONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 083595-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan Institutional TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 040652-001 Dec 11, 2006 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Dash Pharms TESTOSTERONE testosterone SOLUTION, METERED;TRANSDERMAL 212301-001 Jan 11, 2021 AT RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 084401-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE estradiol valerate; testosterone enanthate INJECTABLE;INJECTION 085865-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Sun Pharm Inds Ltd TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 201720-001 Jun 3, 2013 AO RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Colorcon
AstraZeneca
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.